Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab and Carmustine in Relapsed High-Grade Glioma
NCT00795665Phase 2Completed
- Sponsor
- University of California, Davis
- Start
- Jun 2008
- Primary completion
- Dec 2015
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in high-grade glioma (HGG), sponsored by University of California, Davis. Started Jun 2008; status: completed.
02
Drugs
bevacizumab
03
Conditions
high-grade glioma (HGG)
Beyond the preview
Go deeper on NCT00795665.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00795665.